» Articles » PMID: 24877092

The Role of Physical Exercise in Inflammatory Bowel Disease

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 May 31
PMID 24877092
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

We reviewed and analyzed the relationship between physical exercise and inflammatory bowel disease (IBD) which covers a group of chronic, relapsing, and remitting intestinal disorders including Crohn's disease (CD) and ulcerative colitis. The etiology of IBD likely involves a combination of genetic predisposition and environmental risk factors. Physical training has been suggested to be protective against the onset of IBD, but there are inconsistencies in the findings of the published literature. Hypertrophy of the mesenteric white adipose tissue (mWAT) is recognized as a characteristic feature of CD, but its importance for the perpetuation of onset of this intestinal disease is unknown. Adipocytes synthesize proinflammatory and anti-inflammatory cytokines. Hypertrophy of mWAT could play a role as a barrier to the inflammatory process, but recent data suggest that deregulation of adipokine secretion is involved in the pathogenesis of CD. Adipocytokines and macrophage mediators perpetuate the intestinal inflammatory process, leading to mucosal ulcerations along the mesenteric border, a typical feature of CD. Contracting skeletal muscles release biologically active myokines, known to exert the direct anti-inflammatory effects, and inhibit the release of proinflammatory mediators from visceral fat. Further research is required to confirm these observations and establish exercise regimes for IBD patients.

Citing Articles

Nutritional Habits in Crohn's Disease Onset and Management.

Papadimitriou K, Deligiannidou G, Voulgaridou G, Giaginis C, Papadopoulou S Nutrients. 2025; 17(3).

PMID: 39940417 PMC: 11821097. DOI: 10.3390/nu17030559.


mHealth Physical Activity and Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases: Cluster Analysis.

Griffin A, Mentch L, Lin F, Chung A J Med Internet Res. 2024; 26:e48020.

PMID: 39316795 PMC: 11462094. DOI: 10.2196/48020.


Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome.

Li C, Li J, Zhou Q, Wang C, Hu J, Liu C Nutrients. 2024; 16(16).

PMID: 39203794 PMC: 11356817. DOI: 10.3390/nu16162657.


Saffron as a Promising Therapy for Inflammatory Bowel Disease.

Rashid M, Rashid R, Saroya S, Deverapalli M, Brim H, Ashktorab H Nutrients. 2024; 16(14).

PMID: 39064796 PMC: 11280066. DOI: 10.3390/nu16142353.


Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study.

Jo K, Kim K, Lee H, Im J, Kim J, Koh S Intest Res. 2024; 22(4):453-463.

PMID: 38772863 PMC: 11534449. DOI: 10.5217/ir.2024.00044.


References
1.
Bartram S, Peaston R, Rawlings D, Walshaw D, Francis R, Thompson N . Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol. 2006; 12(35):5680-6. PMC: 4088170. DOI: 10.3748/wjg.v12.i35.5680. View

2.
Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, Funahashi T . Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut. 2005; 54(6):789-96. PMC: 1774527. DOI: 10.1136/gut.2004.046516. View

3.
Borley N, Mortensen N, Jewell D, Warren B . The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol. 2000; 190(2):196-202. DOI: 10.1002/(SICI)1096-9896(200002)190:2<196::AID-PATH513>3.0.CO;2-5. View

4.
Chandran M, Phillips S, Ciaraldi T, Henry R . Adiponectin: more than just another fat cell hormone?. Diabetes Care. 2003; 26(8):2442-50. DOI: 10.2337/diacare.26.8.2442. View

5.
Monteleone G, Pallone F, Macdonald T . Emerging immunological targets in inflammatory bowel disease. Curr Opin Pharmacol. 2011; 11(6):640-5. DOI: 10.1016/j.coph.2011.09.013. View